Glenmark Pharmaceuticals to sell certain dermatology brands to Eris Lifesciences
Glenmark Pharmaceuticals has agreed to sell certain brands from its dermatology segment in India and Nepal to Eris Oaknet Healthcare, a fully-owned subsidiary of Eris Lifesciences. The consideration for the deal is INR 340.48 crores, stated the Indian pharma company. The brands being divested are Onabet, Sorvate, Halovate, Demelan, Luligee, Aceret, Revize, Dosetil, and Powercort, […]